Laboratory Products
New Genomic and Somatic Mutation Detection Kits Launched
Nov 01 2012
Multiplicom, a molecular diagnostics company specialising in innovative molecular genetics tests based on massively parallel sequencing (MPS) has announced that it is launching new genomic and somatic mutation detection kits based on its proprietary MASTR technology.
The genomic kits enable PCR amplification of all coding regions of genes known to cause Mucovisidosis, Marfan syndrome, Alport syndrome, Polycystic Kidney Disease, Familial Mediterranean Fever and Duchenne Muscular Dystrophy through the identification of single nucleotide polymorphisms, small deletions/insertions and copy number variations. The EGFR MASTR kit is Multiplicom’s first somatic mutation detection product for the analysis of tumour tissue, targeting exons 18 to 21 of the EGFR gene, key to selecting the most effective treatment options.
These newly launched tests complement Multiplicom’s MASTR product line which can be used in combination with all benchtop MPS instruments. Earlier this month, Multiplicom started shipping BRCA MASTR Dx, its first CE/IVD labelled kit, and is in the process of qualifying other kits for EU regulatory approval.
Dr Dirk Pollet, CEO of Multiplicom, said: “The introduction of the new kits establishes Multiplicom as a European leader in the implementation of MPS in routine diagnostic labs. Multiplicom’s products are simple, easy to use, only require standard equipment and are compatible with MPS equipment from Roche, Life Technologies and Illumina.”
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia